HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Nle4-D-Phe7]-alpha-melanocyte-stimulating hormone significantly increased pigmentation and decreased UV damage in fair-skinned Caucasian volunteers.

Abstract
Epidermal melanin reduces some effects of UV radiation, the major cause of skin cancer. To examine whether induced melanin can provide protection from sunburn injury, 65 subjects completed a trial with the potent synthetic melanotropin, [Nle4-D-Phe7]-alpha-melanocyte-stimulating hormone ([Nle4-D-Phe7]-alpha-MSH) delivered by subcutaneous injection into the abdomen at 0.16 mg/kg for three 10-day cycles over 3 months. Melanin density, measured by reflectance spectroscopy, increased significantly in all [Nle4-D-Phe7]-alpha-MSH-treated subjects. The highest increases were in volunteers with lowest baseline skin melanin levels. In subjects with low minimal erythemal dose (MED) skin type, melanin increased by an average of 41% (from 2.55 to 3.59, P < 0.0001 vs placebo) over eight separate skin sites compared with only 12% (from 4.18 to 4.70, P < 0.0001 vs placebo) in subjects with a high-MED skin type. Epidermal sunburn cells resulting from exposure to 3 MED of UV radiation were reduced by more than 50% after [Nle4-D-Phe7]-alpha-MSH treatment in the volunteers with low baseline MED. Thymine dimer formation was also shown to be reduced by 59% (P = 0.002) in the epidermal basal layer. This study has shown for the first time the potential ability of a synthetic hormone that augments melanin production to provide photoprotection to people who normally burn in direct sunlight.
AuthorsRoss StC Barnetson, Terry K T Ooi, Liqing Zhuang, Gary M Halliday, Catherine M Reid, Patrick C Walker, Stuart M Humphrey, Michael J Kleinig
JournalThe Journal of investigative dermatology (J Invest Dermatol) Vol. 126 Issue 8 Pg. 1869-78 (Aug 2006) ISSN: 0022-202X [Print] United States
PMID16763547 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Anticarcinogenic Agents
  • Melanins
  • Pyrimidine Dimers
  • Sunscreening Agents
  • alpha-MSH
  • MSH, 4-Nle-7-Phe-alpha-
Topics
  • Adult
  • Anticarcinogenic Agents (administration & dosage)
  • Biopsy
  • Epidermal Cells
  • Epidermis (drug effects, pathology)
  • Female
  • Humans
  • Male
  • Melanins (metabolism)
  • Melanocytes (drug effects, metabolism, pathology)
  • Middle Aged
  • Pyrimidine Dimers (metabolism)
  • Skin Pigmentation (drug effects, radiation effects)
  • Sunburn (drug therapy, pathology, prevention & control)
  • Sunscreening Agents (administration & dosage)
  • Ultraviolet Rays (adverse effects)
  • White People
  • alpha-MSH (administration & dosage, analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: